Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR8 | P51685 | 8/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.59 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.58 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 8/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5414730 | 0.88 | CCR8 (0.75) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| Trifluoroacetic Acid SCHEMBL5434940 | 0.88 | CHRM2 (0.61) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| SCHEMBL5414081 | 0.88 | CYP2D6 (0.64) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| SCHEMBL5398771 | 0.88 | CYP2D6 (0.64) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| SCHEMBL5396135 | 0.87 | USP2 (0.59) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| SCHEMBL5399234 | 0.87 | CYP2D6 (0.63) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| SCHEMBL5400189 | 0.87 | CCR8 (0.71) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| SCHEMBL5398775 | 0.86 | CYP2D6 (0.59) | CCR8KCNH2CHRM2CHRM3CYP2D6 | |
| SCHEMBL5403240 | 0.86 | CYP2D6 (0.80) | CCR8KCNH2CYP2D6CYP3A4USP2 | |
| SCHEMBL5403356 | 0.85 | CYP2D6 (0.61) | CCR8KCNH2CHRM2CHRM3CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678178-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | AstraZeneca AB (SE) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005040167-A1 | NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES | ASTRAZENECA AB (SE) | 2005-05-06 | — | — | WO | disclosed |